首页> 外文期刊>Techniques in Neurosurgery >Endovascular Therapy for Cavernous Sinus Vascular Lesions
【24h】

Endovascular Therapy for Cavernous Sinus Vascular Lesions

机译:海绵窦血管病变的血管内治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Vascular lesions in the cavernous sinus can cause serious neurological and ophthalmic complications owing to the anatomic relation of these lesions with important neurovascular structures, including cranial nerves, internal carotid artery, sub-arachnoid spaces, orbital contents, and deep and superficial cerebral venous channels. Well-recognized vascular lesions in the cavernous sinus include direct and indirect carotid-cavernous fistulae and cavernous carotid aneurysms. Over the past two decades, endovascular therapy has provided important therapeutic options for these challenging lesions. Indirect carotid-cavernous fistulae are one subgroup of dural arterio-venous malformations (DAVM). Their clinical significance is dependent on the venous drainage pattern, Ophthalmic complications may also be indications for aggressive therapy. Endovascular transarterial and, particularly, transvenous embolizations have been shown excellent results in managing indirect carotid-cavernous fistulae and low complications. Direct carotid-cavernous fistulae (CCF) are high-flow lesions, usually results of trauma or intracavernous aneurysm rupture. They typically present with progressive ophthalmic complaints and require treatment to prevent visual deterioration. Transarterial balloon and/or coil embolization of CCFs and transvenous coil embolization of the cavernous sinus are effective and safe management options with good results, Cavernous carotid aneurysms are relatively benign with low risk of subarachnoid hemorrhage. However, they may frequently reach giant size, causing mass effect on cavernous sinus contents. With systematic evaluation of the'patient's cerebral circulation and its tolerance to carotid sacrifice, frequently, cavernous carotid aneurysms can be obliterated with permanent carotid occlusion without or with cerebral revascularization. New endovascular techniques, including balloon remodeling and stent assisted coil embolization, have made some constructive therapy possible for obliterating such aneurysms while preserving the parent carotid artery.
机译:由于这些病变与重要的神经血管结构(包括颅神经,颈内动脉,蛛网膜下腔,眶内容以及深浅的脑静脉通道)在解剖学上的关系,导致海绵窦的血管病变可引起严重的神经和眼科并发症。海绵窦的公认血管病变包括直接和间接的颈动脉海绵窦瘘和海绵状颈动脉瘤。在过去的二十年中,血管内治疗为这些具有挑战性的病变提供了重要的治疗选择。间接颈动脉海绵窦瘘是硬脑膜动静脉畸形(DAVM)的一个亚组。它们的临床意义取决于静脉引流方式,眼科并发症也可能是积极治疗的指征。在治疗间接颈动脉海绵窦瘘和低并发症方面,血管内动脉尤其是静脉栓塞已显示出极好的效果。颈动脉海绵窦直接瘘(CCF)是高流量病变,通常是外伤或海绵体内动脉瘤破裂的结果。他们通常会出现进行性眼病,需要进行治疗以防止视力下降。 CCF的经动脉球囊和/或盘管栓塞以及海绵窦的静脉盘管栓塞是有效且安全的治疗选择,效果良好。海绵状颈动脉瘤相对良性,蛛网膜下腔出血的风险较低。但是,它们可能经常达到巨大的尺寸,从而对海绵窦内容物产生质量影响。通过对患者的脑循环及其对颈动脉牺牲的耐受性的系统评价,经常性的颈动脉闭塞可消除海绵状颈动脉瘤,而无需或不进行脑血管重建。包括球囊重塑和支架辅助线圈栓塞在内的新的血管内技术已经使某些构造性疗法成为可能,从而可以消除此类动脉瘤,同时保留颈总动脉。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号